Stay updated with breaking news from Consumer Tissue. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cornerstone Capital Inc. cut its holdings in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 1.7% in the 4th quarter, HoldingsChannel.com reports. The firm owned 141,714 shares of the company’s stock after selling 2,426 shares during the period. Kimberly-Clark comprises approximately 1.9% of Cornerstone Capital Inc.’s portfolio, making the stock its 22nd largest holding. Cornerstone Capital […]
Cornerstone Capital Inc. lowered its position in Kimberly-Clark Co. (NYSE:KMB – Free Report) by 1.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 141,714 shares of the company’s stock after selling 2,426 shares during the quarter. Kimberly-Clark makes up approximately […]
Kimberly-Clark (NYSE:KMB – Free Report) had its price target upped by UBS Group from $135.00 to $138.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a neutral rating on the stock. A number of other brokerages have also recently issued reports on KMB. Barclays lifted their target price on Kimberly-Clark […]
Kimberly-Clark (NYSE:KMB – Free Report) had its target price lifted by Royal Bank of Canada from $123.00 to $126.00 in a report issued on Wednesday morning, Benzinga reports. The firm currently has a sector perform rating on the stock. Several other brokerages have also recently commented on KMB. Piper Sandler increased their target price on […]
Bahl & Gaynor Inc. reduced its stake in shares of Kimberly-Clark Co. (NYSE:KMB – Free Report) by 4.9% during the 4th quarter, HoldingsChannel reports. The fund owned 15,362 shares of the company’s stock after selling 790 shares during the period. Bahl & Gaynor Inc.’s holdings in Kimberly-Clark were worth $1,867,000 at the end of the […]